Less Ads, More Data, More Tools Register for FREE

Pin to quick picks4Imprint Regulatory News (FOUR)

Share Price Information for 4Imprint (FOUR)

Share Price is delayed by 15 minutes
Get Live Data
3,712.00    22.00 (0.60%)
Bid:
3,706.00
Ask:
3,716.00
Spread: 10.00 (0.27%)
Market Cap: £1.04b
FOUR Live PriceLast checked at - London Stock Exchange

Intraday 4Imprint Share Chart

Directorate Change

12 Mar 2025 07:00

RNS Number : 2588A
4imprint Group PLC
12 March 2025
 

12 March 2025

4imprint Group plc

CFO Appointment

 

4imprint Group plc ("4imprint" or the "Company") today announces that Michelle Brukwicki will be appointed as CFO and a member of the Board with effect from 1 May 2025. On the same date, David Seekings will step down as CFO and from the Board, but will remain available to Michelle and the business until 30 June 2025 to ensure a continued smooth transition.

Paul Moody, Chair, commented: Alongside Kevin, David's contribution has been central to the phenomenal success that 4imprint has enjoyed over many years. His personal values and high integrity are evident in all that he has done and his positive commitment to all stakeholders has been unwavering. The Board sends its thanks and wishes him great success and happiness in the future.

Kevin Lyons-Tarr, CEO, commented: David's deep commitment to always doing the right thing for the business and its stakeholders has absolutely been an integral part of our success. From his first day with the Group through to his work to ensure a successful and effective succession, he has always given his very best. Working alongside him for more than two decades has truly been one of the highlights of my career. On behalf of everyone who has been part of the 4imprint journey I offer sincere thanks and best wishes to David and his family as he embarks on this next chapter. 

David Seekings, CFO, commented: During my 28 year career with the Company I have had the privilege of being part of a truly unique business at 4imprint. Over the years I have enjoyed working with many inspiring colleagues, including fellow Board members, Kevin and the leadership group, and all of the talented team members throughout the business who make 4imprint such an exceptional place to work. Whilst looking forward to a full and active retirement, I will miss my daily interactions with the 4imprint team, many of whom I can call my friends.

 

Notes: 

1. There is no further information in respect of Michelle Brukwicki which would require disclosure under Listing Rule 6.4.6.

2. Details of Michelle's remuneration arrangements were set out in the Company's announcement of 18 October 2024.

3. The information required to be disclosed under section 430(2B) of the Companies Act 2006 in relation to David Seekings will be available on the Company's website in due course. Consistent with his contractual terms and the Remuneration Policy, David will be paid salary, pension and benefits in the normal way until 30 June 2025. As a good leaver David will earn a pro rata FY25 bonus in relation to the period to 30 June 2025, and he will retain his outstanding deferred bonus awards, all subject to the relevant conditions. David will be bound by the post-cessation shareholding requirements in the Company's Remuneration Policy, requiring him to retain 4imprint shares to the value of 200% of base salary for a minimum of two years following his departure from the business. 

 

For further information, please contact:

 

4imprint Group plc

Tel. + 44 (0) 20 3709 9680

Email: hq@4imprint.co.uk

MHP Group

Tel. + 44 (0) 7884 494112

Email: 4imprint@mhpgroup.com

 

 

Kevin Lyons-Tarr

Chief Executive Officer

 

Emma Taylor

Company Secretary

Katie Hunt

 

 

Eleni Menikou

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOABRGDXGDBDGUB
Date   Source Headline
6th Apr 20209:12 amRNSEBT Purchase
3rd Apr 202012:07 pmRNSSecond Price Monitoring Extn
3rd Apr 202012:02 pmRNSPrice Monitoring Extension
2nd Apr 20203:34 pmRNSDirector/PDMR Shareholding
1st Apr 202012:03 pmRNSPrice Monitoring Extension
30th Mar 202011:02 amRNSAnnual Financial Report
30th Mar 20208:32 amRNSHolding(s) in Company
26th Mar 202011:43 amRNSHolding(s) in Company
24th Mar 20203:09 pmRNSHolding(s) in Company
24th Mar 202012:02 pmRNSPrice Monitoring Extension
23rd Mar 20204:38 pmRNSPrice Monitoring Extension
20th Mar 202010:15 amRNSPrice Monitoring Extension
19th Mar 20207:00 amRNSCOVID-19 Update
13th Mar 20204:36 pmRNSPrice Monitoring Extension
5th Mar 20204:25 pmRNSHolding(s) in Company
5th Mar 20208:49 amRNSHolding(s) in Company
3rd Mar 20202:38 pmRNSHolding(s) in Company
3rd Mar 20207:00 amRNSFinal Results
26th Feb 20203:55 pmRNSHolding(s) in Company
16th Jan 20207:00 amRNSTrading Update and Notice of Final Results
30th Dec 20197:00 amRNSDirectorate Change
23rd Dec 20192:53 pmRNSHolding(s) in Company
18th Dec 20192:46 pmRNSHolding(s) in Company
17th Dec 20193:01 pmRNSEBT Purchase
6th Nov 20198:30 amRNSHolding(s) in Company
5th Nov 20194:24 pmRNSEBT Purchase
4th Nov 20197:00 amRNSTrading Update
29th Oct 20199:01 amRNSEBT Purchase
25th Oct 20199:22 amRNSHolding(s) in Company
17th Oct 20193:51 pmRNSHolding(s) in Company
3rd Oct 20193:55 pmRNSHolding(s) in Company
3rd Oct 20191:14 pmRNSEBT Purchase
2nd Oct 20194:59 pmRNSHolding(s) in Company
30th Sep 201910:30 amRNSDirector/PDMR Shareholding
13th Sep 20194:38 pmRNSHolding(s) in Company
9th Sep 20199:11 amRNSEBT Purchase
27th Aug 20192:42 pmRNSDirector/PDMR Shareholding
14th Aug 20199:48 amRNSHolding(s) in Company
31st Jul 20197:00 amRNSHalf-year Report
29th Jul 20198:55 amRNSHolding(s) in Company
12th Jul 20194:28 pmRNSHolding(s) in Company
1st Jul 201910:03 amRNSDirector/PDMR Shareholding
25th Jun 20199:11 amRNSHolding(s) in Company
14th Jun 20199:25 amRNSEBT Purchase
20th May 201911:18 amRNSEBT purchase
7th May 20192:21 pmRNSResult of AGM
7th May 20197:00 amRNSAGM Statement
24th Apr 201911:56 amRNSEBT Purchase
4th Apr 201911:21 amRNSHolding(s) in Company
4th Apr 201911:09 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.